SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after reporting stellar positive Phase 2 results for sonelokimab in axial spondyloarthritis, which the community views as potentially best-in-class with deep biologic activity. High anticipation for its upcoming Investor Day, coupled with significant institutional re-accumulation and existing short interest, is fueling widespread discussion of the stock's undervaluation and potential for a substantial rally or even a buyout.

We're a deflationary token that builds utility around our BTC and ETH reserves.  Our main goal is to onboard newbies in the friendliest and safest way, that's why we launched our NFT book (definitely for dummies) on five chains one year ago.  Our new swap generates revenue that combined with our taxes allow us to grow at a slow but steady pace; We're completely sustainable because our monthly expenses are really low.

PiggyCoinBSC

PiggyCoinBSC is trending due to robust community engagement through frequent 'community spaces' on X and Cryptotwits, where a predominantly bullish sentiment is expressed. Discussions center on its unique tokenomics, which include Bitcoin and Ethereum Strategic Reserves, USDC rewards for holders, a buyback and burn mechanism, and its newly launched multi-chain swap platform, Swappy.cool, all contributing to its perceived long-term potential within DeFi.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MULN crypto token is trending, frequently confused with the highly controversial Mullen Automotive stock, leading to a polarized community discussion; while a small group attempts to rally a "Mullen Army" with claims of utility, the broader sentiment warns of it being a "scam coin" with extremely low volume and potential for further decline.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is seeing significant buzz driven by its recent multiple exchange listings and robust AI agent utility on the Base ecosystem, with the community actively discussing its strong revenue generation and potential for substantial growth, often contrasting its performance with broader crypto market trends.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group (DJT) is trending after the Supreme Court's ruling on tariffs prompted Donald Trump to announce an immediate increase in global tariffs to 15%, fueling intense debate on his economic policies and their potential impact. The community remains sharply divided, discussing whether this move is a strategic victory or a detrimental policy that could impact the broader economy, alongside ongoing speculation about the stock's underlying financials.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following the FDA approval of BYSANTI, its second major drug approval in two months, igniting widespread community speculation about its long-term revenue potential and a significant buyout from major pharmaceutical companies seeking to fill patent cliffs, especially given the anticipated blockbuster impact of its Tradipitant pipeline.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

BITI is trending as the community debates allegations connecting Jeffrey Epstein's criminal activities to early Bitcoin funding, fueling a strong sentiment that Bitcoin, now widely called "pedo-currency," is destined for zero.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

Bitdeer is trending amid a strategic pivot to AI/HPC cloud services and data center expansion, supported by solid Q4 revenue and a large capital raise; however, the community is actively debating the impact of this substantial dilution and the sale of all its Bitcoin holdings, leading to significant stock volatility.

Allegiant Travel Co. engages in the provision of leisure travel services. It operates through the Airline and Sunseeker Resort segments. The Airline segment involves the scheduled service air transportation, ancillary air-related and third-party products and services, fixed fee contract air transportation, and other airline-related revenue. The Sunseeker Resort segment includes hotel rooms and suites for occupancy, group meeting facilities, food and beverage options, the Aileron Golf Course, and other resort amenities. The company was founded in 1997 and is headquartered in Las Vegas, NV.

Allegiant Travel

Allegiant Travel is trending due to its robust Q4 2025 earnings and revenue beat, which has sparked multiple analyst price target increases, alongside community relief and renewed focus following the strategic divestment of its problematic Sunseeker Resort.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending amidst fervent community discussion surrounding the "Clarity Act" and its potential to classify the token as a vital digital commodity for collateralized payments, with supporters anticipating institutional adoption and significant utility, while a skeptical segment voices frustration over years of underperformance and perceived lack of development.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Revolution Medicines, Inc. $RVMD Stock Position Decreased by Principal Financial Group Inc.

Principal Financial Group Inc. decreased its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 90.8% during the 3rd quarter, according to the company in its most recent...

China Universal Asset Management Co. Ltd. Sells 34,644 Shares of Revolution Medicines, Inc. $RVMD

China Universal Asset Management Co. Ltd. decreased its position in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 44.8% during the third quarter, according to the company in its most...

NEOS Investment Management LLC Acquires 32,694 Shares of Revolution Medicines, Inc. $RVMD

NEOS Investment Management LLC raised its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 34.7% during the 3rd quarter, according to its most recent filing with the...

Revolution Medicines (RVMD) to Release Earnings on Wednesday

Revolution Medicines (NASDAQ:RVMD) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...

Revolution Medicines Conference: CEO Details Daraxonrasib Phase III Timeline, First-Line PDAC Push

Revolution Medicines (NASDAQ:RVMD) CEO Mark Goldsmith outlined the company's late-stage plans for its RAS(ON) inhibitor daraxonrasib, discussed expansion into first-line pancreatic cancer, and...

Revolution Medicines, Inc. $RVMD Shares Sold by Allianz Asset Management GmbH

Allianz Asset Management GmbH trimmed its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 40.0% during the third quarter, according to its most recent filing with the...

Noteworthy Monday Option Activity: RVMD, BLSH, MDB

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Revolution Medicines Inc (Symbol: RVMD), where a total volume of 24,146 contracts...

Stock Traders Purchase High Volume of Put Options on Revolution Medicines (NASDAQ:RVMD)

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) was the recipient of some unusual options trading activity on Monday. Traders acquired 22,906 put options on the company. This is an...

Revolution Medicines, Inc. $RVMD Shares Bought by Candriam S.C.A.

Candriam S.C.A. raised its position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 20.7% in the third quarter, according to its most recent Form 13F filing with the Securities...

Revolution Medicines, Inc. $RVMD Shares Acquired by New York State Common Retirement Fund

New York State Common Retirement Fund lifted its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 39.3% during the 3rd quarter, according to the company in its most recent...

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$1.58	--	--	N/A
Q3 '25	-$1.42	-$1.61	-13.29%	MISSED
Q2 '25	-$1.12	-$1.31	-16.60%	MISSED
Q1 '25	-$1.10	-$1.13	-3.01%	MISSED
Q4 '24	-$0.99	-$1.12	-13.61%	MISSED

RVMD
Revolution Medicines Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest RVMD News

RVMDRevolution Medicines Inc